Join the Immunization Economics pre-congress session at the iHEA congress: July 13-14, Basel, Switzerland. Some funding available ($2500 each) to support travel. Abstract submission/application opens until March 29
The EPIC project is proud to announce the Sample Design Optimizer (SDO) instrument. This instrument aims to assist research teams develop cost-effective and efficient sample design to maximize expected precision within a data collection budget constraint.
Get an overview of transitioning countries’ progress with LNCT’s new transition dashboards. See progress and challenges across LNCT countries and detailed progress for each country, compared with the LNCT group of countries.
Using examples from immunizations, a recent TVEE training focuses on develop skills in economic evaluations, carrying out a cost-effectiveness/budget impact analysis, and building local capacity in vaccine economics
Dr. Orin Levine’s new piece for CBS discusses how resurgent measles outbreaks are underscoring the importance of vaccines. In today's interconnected world, outbreaks of infectious diseases anywhere are a threat to us everywhere.
This is a crowd-sourced list of publications related to the economics of immunization, and will be updated periodically. We rely on community members (YOU!) to share their materials with the broader Immunization Economics community of practice.
As part of the 2019 iHEA biennial world congress, the 2-day Immunization Economics session will feature new updates, refresher course, panel discussion, and social networking event. Some funding support available
Assessment of measles mortality burden is highly dependent on measures of measles case fatality ratios (CFRs). This new analysis estimates measles CFRs across heterogeneous groupings (by country; income level; year; age) through 2030.
A new commentary by Kimberly Thompson discusses the new epidemiological model by Portnoy et al. This model estimates case-fatality ratios for measles in low-income and middle-income countries up to 2030
Funding is available to support academics in bacterial vaccinology to explore new approaches and strategies to advance their vaccines in partnership with LMICs and industry. Apply by May 5
A new working paper provides a practical guide on immunization costing primary data collection and analysis. We would like to invite the Immunization Economics community to explore the working paper and provide feedback
Did you know that the models developed by the DOVE project estimate the costs averted by vaccination? The models focuses on ten antigens and 94 low- and middle-income countries, 2001-2030. Results are used at the global and regional level to advocate for new vaccine introduction and increased coverage.
We identified these 10 articles related to the economics of immunization. These articles were gathered from the START Center Vaccine Delivery Research Digest resource — up to the latest issue in January 2019
Immunization spending data play a key role in informing policy and planning. In this recently published webinar video, panel of experts discuss how countries can better produce, analyze, and present immunization spending data.
The Immunization Costing Action Network (ICAN) will develop methodological guidance and a customizable costing tool to support the costing of immunization campaigns. They will also conduct 3 campaign costing studies this year. You are invited to provide input.
New video features the Immunization Costing Action Network (ICAN). The ICAN bridges critical gap in immunization economics policymaking and implementation through their country work and cost catalogue
In this Learning Network for Countries in Transition (LNCT) blog, R4D’s Helen Saxenian, Leah Ewald, and Meghan O’Connell and Logan Brenzel from the Gates Foundation outline 4 things ministers of finance need to know about immunization in Gavi transitioning countries
New research looking into the extra dividends of vaccination will formally quantify the broad benefits of measles vaccination on childhood health,and the long-term labor-market gains.
A recent commentary by the DOVE project explored the economic burden of pneumonia, diarrhea, and measles for households in Uganda. This is the first-ever study of such kind in Uganda, and policy makers are taking notice
The Immunization Resource Tracking Project at Abt Associates has developed resources to promote the production and use of immunization expenditure data - from policy briefs and a policy primer, to a podcast and webinar.
New podcast focused on ensuring adequate resources for immunization services, includes tips and tools for immunization program managers. Hear from global experts on why spending data is becoming more important for immunization programs
Upcoming March meeting in Washington D.C. will highlight the results of the benefit-cost analysis reference case guidance project, applicable to immunization and other policies in low- and middle-income countries. Dean Jamison plenary speaker.
Promising immunizations for diseases that affect mostly people in low- and middle-income countries need help getting to market, urge David C. Kaslow and colleagues.
A new special issue of PNAS focuses on the role of vaccination in fighting antimicrobial resistance.
Public health researchers discuss the importance of making economic evaluations of vaccines AMR-sensitive, outline how this can be done, and offer a roadmap for future research. read more here
Following a call for concept notes last year, the VoVRN Secretariat, members of the Steering Committee, and external expert reviewers identified promising studies to recommend for funding. Learn more about these projects here
A more efficient, effective and resilient supply chain means more time for health services. A study found 22% more doses delivered following the initiative in the Democratic Republic of Congo. read more here
Although vaccines continue to protect millions against debilitating, life-threatening diseases; new WHO report starkly illustrates how easily hard-won gains are lost.. Read key messages or download full report.
Submit new information [here]